 BEIJING--BUSINESS WIRE--Genetron Holdings Limited Genetron Health or the Company, NASDAQ:GTH, a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced unaudited preliminary financial results for the fourth quarter and full year ended December 31, 2020. 2020 Financial Highlights Recorded total revenue of RMB133.9 million US20.5 million for the fo 